- Home
- LVTX vs ANVS Comparison
LVTX vs ANVS Comparison
Compare LVTX & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- ANVS
- Stock Information
- Founded
- LVTX 2016
- ANVS 2008
- Country
- LVTX Netherlands
- ANVS United States
- Employees
- LVTX N/A
- ANVS N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- LVTX Health Care
- ANVS Health Care
- Exchange
- LVTX Nasdaq
- ANVS Nasdaq
- Market Cap
- LVTX 34.2M
- ANVS 31.2M
- IPO Year
- LVTX 2021
- ANVS 2020
- Fundamental
- Price
- LVTX $1.25
- ANVS $1.46
- Analyst Decision
- LVTX Hold
- ANVS Strong Buy
- Analyst Count
- LVTX 3
- ANVS 5
- Target Price
- LVTX $3.17
- ANVS $37.00
- AVG Volume (30 Days)
- LVTX 72.6K
- ANVS 272.8K
- Earning Date
- LVTX 03-28-2025
- ANVS 03-21-2025
- Dividend Yield
- LVTX N/A
- ANVS N/A
- EPS Growth
- LVTX N/A
- ANVS N/A
- EPS
- LVTX N/A
- ANVS N/A
- Revenue
- LVTX $11,982,000.00
- ANVS N/A
- Revenue This Year
- LVTX $16.68
- ANVS N/A
- Revenue Next Year
- LVTX N/A
- ANVS N/A
- P/E Ratio
- LVTX N/A
- ANVS N/A
- Revenue Growth
- LVTX 77.01
- ANVS N/A
- 52 Week Low
- LVTX $0.85
- ANVS $1.53
- 52 Week High
- LVTX $3.57
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- LVTX 49.47
- ANVS 31.94
- Support Level
- LVTX $1.20
- ANVS $1.72
- Resistance Level
- LVTX $1.36
- ANVS $2.07
- Average True Range (ATR)
- LVTX 0.08
- ANVS 0.13
- MACD
- LVTX -0.02
- ANVS 0.06
- Stochastic Oscillator
- LVTX 29.41
- ANVS 0.91
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.